-
EP2228652
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2228652
| EP2228652 - Improvement of tumour treatment [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.08.2011 Database last updated on 14.06.2024 | Most recent event Tooltip | 19.08.2011 | Application deemed to be withdrawn | published on 21.09.2011 [2011/38] | Applicant(s) | For all designated states Medizinische Universität Wien Spitalgasse 23 1090 Vienna / AT | [2010/37] | Inventor(s) | 01 /
Krainer, Michael Glanzinggasse 25 1190 Vienna / AT | 02 /
Wittinger, Michael Wurlitzergasse 13/21 1160 Vienna / AT | [2010/37] | Representative(s) | SONN Patentanwälte GmbH & Co KG Riemergasse 14 1010 Wien / AT | [N/P] |
| Former [2010/37] | Sonn & Partner Patentanwälte Riemergasse 14 1010 Wien / AT | Application number, filing date | 09154836.2 | 11.03.2009 | [2010/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2228652 | Date: | 15.09.2010 | Language: | EN | [2010/37] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.08.2009 | Classification | IPC: | G01N33/52 | [2010/37] | CPC: |
G01N33/57484 (EP,US);
C07K16/2863 (EP,US);
C07K16/303 (EP,US);
G01N33/574 (EP,US);
G01N33/57449 (EP,US);
A61K2039/505 (EP,US);
| Designated contracting states | [2011/20] |
| Former [2010/37] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | Verbesserung bei der Tumorbehandlung | [2010/37] | English: | Improvement of tumour treatment | [2010/37] | French: | Amélioration du traitement de tumeur | [2010/37] | Examination procedure | 16.03.2011 | Application deemed to be withdrawn, date of legal effect [2011/38] | 04.05.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2011/38] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.03.2011 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2006116323 (ZHAO MUJUN [CN], et al) [Y] 1-15 * page 1, paragraphs 10-14,21; example 4; claim 10; sequences 1, 2 * * page 2, paragraphs 23, 28,32 * * page 3, paragraph 40 * * page 5, paragraphs 70,74, 75 *; | [X] - GRANDAL MICHAEL VIBO ET AL, "Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis.", JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 2008 SEP-OCT, (200809), vol. 12, no. 5A, ISSN 1582-1838, pages 1527 - 1534, XP002523169 [X] 1-15 * page 1528, column 2, line 21 - page 1529, column 1, line 3 * * page 1529, column 1, lines 16-27 * * page 1529, column 2, lines 17-21 * * page 1530, column 2, lines 29-44 * * page 1531, column 1, lines 4-28 * * page 1531, column 2, lines 38-40 * * page 1531, column 2, lines 46-49 * * page 1532, column 2, lines 5-13 * DOI: http://dx.doi.org/10.1111/J.1582-4934.2008.00298.X | [Y] - WANG Z ET AL, "Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.", MOLECULAR BIOLOGY OF THE CELL MAY 1999, (199905), vol. 10, no. 5, ISSN 1059-1524, pages 1621 - 1636, XP002523170 [Y] 1-15 * abstract * * page 1622, column 1, lines 38-41 * * page 1622, column 2, lines 17-19 * * page 1623, column 1, lines 23-25 * * page 1625, column 2, line 11 - page 1628, column 2, line 10 * * page 1630, column 2, lines 22-26 * * page 1631, column 2, lines 5-14 * * page 1633, column 1, line 16 - page 1633, column 2, line 32 * | [Y] - KIRISITS ET AL, "Epidermal growth factor receptor degradation: An alternative view of oncogenic pathways", INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, EXETER, GB, (20070101), vol. 39, no. 12, ISSN 1357-2725, pages 2173 - 2182, XP022277792 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.biocel.2007.07.012 | by applicant | EP0186833 | WO9216553 | US6090923 | US2004127470 | US2006116323 | WO2007050495 | - DANCEY ET AL., NATURE REVIEWS DRUG DISCOVERY, (2003), vol. 2, pages 296 - 313 | - BAR- RETT ET AL., NUCLEIC ACIDS RESEARCH, (2005), vol. 33, pages D562 - D566 | - XU ET AL., BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (2003), vol. 311, pages 1057 - 1066 | - REI- CHERT ET AL., NATURE REVIEWS DRUG DISCOVERY, (2007), vol. 6, pages 349 - 356 | - NAT.REV.DRUG DISC., (2004), vol. 3, pages 549 - 550 | - NAT.REV.DRUG DISC., (2006), vol. 5, pages 987 - 988 | - YARDEN ET AL., NATURE REVIEWS MOLECULAR CELL BIOLOGY, (2001), vol. 2, pages 127 - 137 |